Patent Yard Sign in
European application, no grantEurope

Formulation having a papilloma virus-specific protein, and the production and use thereof

EP 1066321 A2 · Applicant: MediGene Aktiengesellschaft

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed March 24, 1999 and never granted as a European patent. Had it been granted, its 20-year term would have ended March 24, 2019.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 24, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 24, 1999
PublishedJanuary 10, 2001
GrantedNever granted
Term endedMarch 24, 2019
Application numberEP 99917850
Classification (CPC)A61P35/00 +2 more

Timeline

Timeline From EPO dates

2000200220042006200820102012201420162018Application filedMarch 24, 1999PublishedJan 10, 2001Term endedMarch 24, 2019

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.